PT Kimia Farma (Persero) Tbk (KAEF.JK)
IDR 600.0
(-0.83%)
IDR 600.0
(-0.83%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 9965.03 Billion IDR | 3.74% |
| 2022 | 9606.14 Billion IDR | -25.29% |
| 2021 | 12857.62 Billion IDR | 28.5% |
| 2020 | 10006.17 Billion IDR | 6.44% |
| 2019 | 9400.53 Billion IDR | 26.11% |
| 2018 | 7454.11 Billion IDR | 21.65% |
| 2017 | 6127.47 Billion IDR | 5.44% |
| 2016 | 5811.5 Billion IDR | 19.57% |
| 2015 | 4860.37 Billion IDR | 7.51% |
| 2014 | 4521.02 Billion IDR | 3.98% |
| 2013 | 4348.07 Billion IDR | 16.44% |
| 2012 | 3734.24 Billion IDR | 7.27% |
| 2011 | 3481.16 Billion IDR | 9.34% |
| 2010 | 3183.82 Billion IDR | 11.55% |
| 2009 | 2854.05 Billion IDR | 5.52% |
| 2008 | 2704.72 Billion IDR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 2535.77 Billion IDR | 12.71% |
| 2024 Q3 | 2650.56 Billion IDR | -1.02% |
| 2024 Q2 | 2677.91 Billion IDR | 5.61% |
| 2023 Q4 | 2249.75 Billion IDR | -18.75% |
| 2023 Q1 | 2303.67 Billion IDR | -6.83% |
| 2023 FY | 9965.03 Billion IDR | 3.74% |
| 2023 Q2 | 2642.76 Billion IDR | 14.72% |
| 2023 Q3 | 2768.83 Billion IDR | 4.77% |
| 2022 Q3 | 2708.55 Billion IDR | 25.13% |
| 2022 FY | 9606.14 Billion IDR | -25.29% |
| 2022 Q4 | 2472.44 Billion IDR | -8.72% |
| 2022 Q2 | 2164.63 Billion IDR | -4.24% |
| 2022 Q1 | 2260.5 Billion IDR | -32.8% |
| 2021 Q1 | 2300.19 Billion IDR | -22.3% |
| 2021 Q4 | 3364.03 Billion IDR | -14.51% |
| 2021 FY | 12857.62 Billion IDR | 28.5% |
| 2021 Q3 | 3935.06 Billion IDR | 20.77% |
| 2021 Q2 | 3258.32 Billion IDR | 41.65% |
| 2020 Q1 | 2402.27 Billion IDR | -4.73% |
| 2020 FY | 10006.17 Billion IDR | 6.44% |
| 2020 Q2 | 2285.52 Billion IDR | -4.86% |
| 2020 Q3 | 2357.88 Billion IDR | 3.17% |
| 2020 Q4 | 2960.48 Billion IDR | 25.56% |
| 2019 Q4 | 2521.63 Billion IDR | 7.12% |
| 2019 Q1 | 1814.82 Billion IDR | -15.46% |
| 2019 Q2 | 2709.99 Billion IDR | 49.32% |
| 2019 Q3 | 2354.08 Billion IDR | -13.13% |
| 2019 FY | 9400.53 Billion IDR | 26.11% |
| 2018 Q4 | 2146.74 Billion IDR | 12.67% |
| 2018 Q2 | 1911.81 Billion IDR | 28.29% |
| 2018 Q1 | 1490.18 Billion IDR | -18.37% |
| 2018 FY | 7454.11 Billion IDR | 21.65% |
| 2018 Q3 | 1905.36 Billion IDR | -0.34% |
| 2017 Q3 | 1666.42 Billion IDR | 15.92% |
| 2017 Q4 | 1825.5 Billion IDR | 9.55% |
| 2017 Q2 | 1437.58 Billion IDR | 20.0% |
| 2017 Q1 | 1197.96 Billion IDR | -35.03% |
| 2017 FY | 6127.47 Billion IDR | 5.44% |
| 2016 Q2 | 1351.24 Billion IDR | 18.67% |
| 2016 FY | 5811.5 Billion IDR | 19.57% |
| 2016 Q4 | 1843.76 Billion IDR | 24.76% |
| 2016 Q1 | 1138.65 Billion IDR | -17.85% |
| 2016 Q3 | 1477.84 Billion IDR | 9.37% |
| 2015 Q3 | 1365.52 Billion IDR | 24.85% |
| 2015 FY | 4860.37 Billion IDR | 7.51% |
| 2015 Q1 | 1015.01 Billion IDR | -29.67% |
| 2015 Q2 | 1093.77 Billion IDR | 7.76% |
| 2015 Q4 | 1386.04 Billion IDR | 1.5% |
| 2014 Q4 | 1443.13 Billion IDR | 22.46% |
| 2014 FY | 4521.02 Billion IDR | 3.98% |
| 2014 Q1 | 867.02 Billion IDR | -43.4% |
| 2014 Q3 | 1178.49 Billion IDR | 14.16% |
| 2014 Q2 | 1032.36 Billion IDR | 19.07% |
| 2013 Q1 | 799.49 Billion IDR | -17.55% |
| 2013 Q3 | 1075.14 Billion IDR | 14.2% |
| 2013 Q4 | 1531.97 Billion IDR | 42.49% |
| 2013 FY | 4348.07 Billion IDR | 16.44% |
| 2013 Q2 | 941.45 Billion IDR | 17.76% |
| 2012 Q3 | 1181.14 Billion IDR | 35.2% |
| 2012 Q4 | 969.62 Billion IDR | -17.91% |
| 2012 Q1 | 709.84 Billion IDR | -33.08% |
| 2012 Q2 | 873.62 Billion IDR | 23.07% |
| 2012 FY | 3734.24 Billion IDR | 7.27% |
| 2011 Q2 | 775.27 Billion IDR | 22.21% |
| 2011 Q3 | 1010.81 Billion IDR | 30.38% |
| 2011 Q4 | 1060.69 Billion IDR | 4.93% |
| 2011 FY | 3481.16 Billion IDR | 9.34% |
| 2011 Q1 | 634.38 Billion IDR | 0.0% |
| 2010 FY | 3183.82 Billion IDR | 11.55% |
| 2009 FY | 2854.05 Billion IDR | 5.52% |
| 2008 FY | 2704.72 Billion IDR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| PT Enseval Putera Megatrading Tbk. | 28507.87 Billion IDR | 65.045% |
| PT Itama Ranoraya Tbk | 696.3 Billion IDR | -1331.133% |
| PT Millennium Pharmacon International Tbk | 3363.51 Billion IDR | -196.268% |
| PT Soho Global Health Tbk | 8197.75 Billion IDR | -21.558% |